 | Aeglea BioTherapeutics to Participate in Two Virtual Investor Conferences in April 2021 finance.yahoo.com - April 1 at 5:58 PM |
 | Aeglea BioTherapeutics and Immedica Announce Commercialization Agreement for Pegzilarginase for the Treatment of Arginase 1 Deficiency in Europe and Middle East finance.yahoo.com - March 22 at 10:31 AM |
 | Aeglea BioTherapeutics (NASDAQ:AGLE) Releases Quarterly Earnings Results, Misses Expectations By $0.04 EPS americanbankingnews.com - March 19 at 8:14 AM |
 | Aeglea BioTherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Highlights finance.yahoo.com - March 18 at 12:34 PM |
 | Aeglea BioTherapeutics Appoints Sara Brownstein to Board of Directors finance.yahoo.com - February 24 at 5:03 PM |
 | We Think Aeglea BioTherapeutics (NASDAQ:AGLE) Needs To Drive Business Growth Carefully finance.yahoo.com - February 18 at 9:29 AM |
 | AGLE Feb 2021 7.500 call ca.finance.yahoo.com - January 23 at 5:00 PM |
 | Aeglea BioTherapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference finance.yahoo.com - January 4 at 4:41 PM |
 | Aeglea (AGLE) Upgraded to Buy: Here's Why finance.yahoo.com - December 30 at 12:55 PM |
 | Is AGLE A Good Stock To Buy Now According To Hedge Funds? finance.yahoo.com - December 19 at 12:41 AM |
|
 | Aeglea BioTherapeutics Appoints Alison Lawton to Board of Directors finance.yahoo.com - December 17 at 6:36 PM |
 | Aeglea Bio's ACN00177 nabs Rare Pediatric status for inherited metabolic disorder seekingalpha.com - December 1 at 4:27 PM |
 | Aeglea BioTherapeutics Receives FDA Rare Pediatric Disease Designation for ACN00177 for the Treatment of Homocystinuria finance.yahoo.com - December 1 at 8:33 AM |
 | Aeglea BioTherapeutics to Participate in Two Upcoming Virtual Investor Conferences finance.yahoo.com - November 17 at 5:57 PM |
 | How Much Are Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) Insiders Spending On Buying Shares? finance.yahoo.com - November 10 at 8:26 AM |
 | Aeglea BioTherapeutics Reports Third Quarter 2020 Financial Results and Corporate Highlights markets.businessinsider.com - November 5 at 9:12 AM |
 | Is a Surprise Coming for Aeglea (AGLE) This Earnings Season? finance.yahoo.com - November 3 at 9:50 AM |
 | Aeglea BioTherapeutics Announces U.S. and EU Orphan Drug Designations for ACN00177 for the Treatment of Homocystinuria finance.yahoo.com - October 26 at 8:52 AM |
 | Is Aeglea BioTherapeutics (NASDAQ:AGLE) In A Good Position To Invest In Growth? finance.yahoo.com - September 11 at 7:31 AM |
 | Aeglea BioTherapeutics to Participate in September Investment Conferences finance.yahoo.com - September 2 at 5:40 PM |
 | Aeglea (AGLE) Looks Good: Stock Adds 5.8% in Session finance.yahoo.com - August 25 at 1:51 PM |
 | Aeglea BioTherapeutics to Present at World Orphan Drug Congress USA 2020 finance.yahoo.com - August 18 at 4:37 PM |
 | Aeglea BioTherapeutics Inc. barrons.com - August 14 at 2:34 PM |
 | Aeglea BioTherapeutics Reports Second Quarter 2020 Financial Results and Corporate Highlights finance.yahoo.com - August 10 at 9:31 AM |
 | How Should Investors React To Aeglea BioTherapeutics' (NASDAQ:AGLE) CEO Pay? finance.yahoo.com - July 13 at 1:31 PM |
 | How Should Investors React To Aeglea BioTherapeutics' (NASDAQ:AGLE) CEO Pay? finance.yahoo.com - July 13 at 1:31 PM |
 | BRIEF-Aeglea Bio Therapeutics Inc Files For Mixed Shelf Of Upto $400 Million uk.reuters.com - July 6 at 11:36 PM |
 | Here's Why Momentum Investors Will Love Aeglea Biotherapeutics (AGLE) www.nasdaq.com - June 29 at 5:43 PM |
|
 | Here's Why Momentum Investors Will Love Aeglea Biotherapeutics (AGLE) finance.yahoo.com - June 29 at 12:43 PM |
 | Aeglea BioTherapeutics (AGLE) Catches Eye: Stock Jumps 5.1% finance.yahoo.com - June 23 at 12:17 PM |
 | Has Aeglea BioTherapeutics (AGLE) Outpaced Other Medical Stocks This Year? finance.yahoo.com - June 10 at 1:34 PM |
 | Why Aeglea BioTherapeutics (AGLE) Stock Might be a Great Pick finance.yahoo.com - June 8 at 1:47 PM |
 | Aeglea BioTherapeutics to Present at BIO Digital 2020 finance.yahoo.com - June 1 at 5:33 PM |
 | Aeglea BioTherapeutics' Shares March Higher, Can It Continue? finance.yahoo.com - May 29 at 2:43 PM |
 | Aeglea BioTherapeutics Announces Change of Location of Annual Meeting of Stockholders to Be Held June 8, 2020 finance.yahoo.com - May 28 at 6:21 PM |
 | Menlo Therapeutics (MNLO) Catches Eye: Stock Jumps 7.1% finance.yahoo.com - May 27 at 12:05 PM |
 | Aeglea BioTherapeutics Announces 1-Year Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 6th Congress of the European Academy of Neurology finance.yahoo.com - May 26 at 11:01 AM |
 | Is Aeglea BioTherapeutics (AGLE) Outperforming Other Medical Stocks This Year? finance.yahoo.com - May 21 at 1:29 PM |
 | Zacks.com featured highlights include: Aeglea BioTherapeutics, VeriSign, Sequans Communications and New Jersey Resources finance.yahoo.com - May 20 at 9:49 AM |
 | Find Strong Stocks During the Coronavirus with New Analyst Coverage finance.yahoo.com - May 20 at 4:29 AM |
 | Aeglea BioTherapeutics Reports First Quarter 2020 Financial Results and Corporate Highlights finance.yahoo.com - May 7 at 1:56 PM |
 | Is Aeglea BioTherapeutics (AGLE) Stock a Solid Choice Right Now? finance.yahoo.com - May 7 at 1:56 PM |
 | Aeglea BioTherapeutics, Inc. (AGLE) Shares March Higher, Can It Continue? finance.yahoo.com - May 6 at 11:35 AM |
 | Anthony Quinn Is The President of Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) And They Just Picked Up 44% More Shares finance.yahoo.com - May 6 at 6:30 AM |
 | Aeglea (AGLE) Upgraded to Strong Buy: What Does It Mean for the Stock? finance.yahoo.com - May 5 at 3:29 PM |
 | Aeglea BioTherapeutics Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares www.marketwatch.com - April 30 at 9:05 PM |
 | Aeglea BioTherapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares finance.yahoo.com - April 30 at 9:05 PM |
 | Stock Alert: Aeglea BioTherapeutics Up 18% www.nasdaq.com - April 28 at 11:13 AM |
 | Aeglea BioTherapeutics Announces Pricing of $120 Million Public Offering finance.yahoo.com - April 28 at 11:13 AM |
 | Aeglea BioTherapeutics Announces Proposed Public Offering finance.yahoo.com - April 27 at 6:43 PM |